Enanta Pharmaceuticals
ENTA
ENTA
151 hedge funds and large institutions have $811M invested in Enanta Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 57 increasing their positions, 60 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
12% less funds holding
Funds holding: 172 → 151 (-21)
70% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 30
98% less call options, than puts
Call options by funds: $58K | Put options by funds: $3.57M
Holders
151
Holding in Top 10
2
Calls
$58K
Puts
$3.57M
Top Buyers
| 1 | +$35M | |
| 2 | +$8.83M | |
| 3 | +$8.02M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$4.84M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.35M |
Top Sellers
| 1 | -$20.9M | |
| 2 | -$7.39M | |
| 3 | -$6.24M | |
| 4 |
First Manhattan
New York
|
-$5.78M |
| 5 |
Man Group
London,
United Kingdom
|
-$2.38M |